Mucciardi Giuseppe, Gali' Alessandro, Barresi Valeria, Mucciardi Massimo, Aguennouz M'Hammemd, Inferrera Antonino, Magno Carlo
Department of Urology, University of Messina, Italy.
Department of Human Pathology, University of Messina, Italy.
Indian J Urol. 2014 Jul;30(3):245-51. doi: 10.4103/0970-1591.134241.
Shortening of telomere is associated with cellular senescence and cancer. This study aims to investigate the relationship between tumor grade and recurrence in relation to telomere length (TL), telomerase activity (TA) and telomere-binding proteins expression (TBPs) in patients with non-muscle invasive bladder cancer (NMIBC).
Tumor/healthy tissues were collected from 58 patients (35 with and 23 without NMIBC). Cystoscopy was performed at 3, 6 and 12 months to determine recurrence. Tumor grades and recurrence were correlated with TL, TA and TBPs using the Kruskal-Wallis non-parametric test. Results were considered significant at P < 0.05.
Histological evaluation indicated 15 patients (42.9%) with high-grade (HG) and 20 patients (57.1%) with low-grade (LG) NMIBC. TL, TA and TBPs were found to be significantly different in tumors as compared with controls. A significant (P < 0.05) difference in the expression of TBPs was observed in the disease-free mucosa of cancer patients as compared with HG and LG tumors. In the follow-up, a total of 11 tumor recurrences were observed; among these eight recurrences were observed in patients with HG tumors and three in patients with LG tumors. TL, Human telomerase reverse transcriptase (hTERT) (that represents TA) and poly (ADP-ribose) polymerase 1 (PARP-1) in tumor samples and telomeric repeat binding factors TRF1, TRF2 and tankyrase (TANK) in normal mucosa obtained from the tumor group were respectively found to exhibit a positive and negative association with the risk of recurrence.
Our study demonstrates that TL, TA and TBPs are altered in tumors and non-cancerous mucosa in patients with papillary urothelial NMIBC. Further studies are warranted to identify their suitability as a potential biomarker.
端粒缩短与细胞衰老和癌症相关。本研究旨在探讨非肌层浸润性膀胱癌(NMIBC)患者的肿瘤分级和复发与端粒长度(TL)、端粒酶活性(TA)及端粒结合蛋白表达(TBPs)之间的关系。
收集58例患者(35例NMIBC患者和23例非NMIBC患者)的肿瘤/健康组织。在3、6和12个月时进行膀胱镜检查以确定复发情况。使用Kruskal-Wallis非参数检验将肿瘤分级和复发与TL、TA和TBPs进行相关性分析。P < 0.05时结果被认为具有显著性。
组织学评估显示,15例患者(42.9%)为高级别(HG)NMIBC,20例患者(57.1%)为低级别(LG)NMIBC。与对照组相比,肿瘤中的TL、TA和TBPs存在显著差异。与HG和LG肿瘤相比,在癌症患者的无病黏膜中观察到TBPs表达存在显著(P < 0.05)差异。在随访中,共观察到11例肿瘤复发;其中,HG肿瘤患者中有8例复发,LG肿瘤患者中有3例复发。分别发现肿瘤样本中的TL、人端粒酶逆转录酶(hTERT,代表TA)和聚(ADP - 核糖)聚合酶1(PARP - 1)以及从肿瘤组获得的正常黏膜中的端粒重复结合因子TRF1、TRF2和端锚聚合酶(TANK)与复发风险呈正相关和负相关。
我们的研究表明,乳头状尿路上皮NMIBC患者的肿瘤和非癌性黏膜中的TL、TA和TBPs发生了改变。有必要进一步研究以确定它们作为潜在生物标志物的适用性。